Testing kidney injury risk from cisplatin cancer treatment
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older (or, if under 18, you are older than 3 months)
- You are starting cisplatin (at least 75 mg/m²) for head/neck or lung cancer if an adult
- If you are a child, you are starting cisplatin for any cancer type
- You must be able to give informed consent (or the legal guardian can, for children)
- You cannot already have chronic kidney disease (poor kidney function before starting)
- You cannot have taken certain kidney-harming medicines in the last 2 weeks or have used cisplatin before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a medicine called aminophylline can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce kidney side effects for people getting cisplatin.
This study tests whether a supplement called N-acetylcysteine (a type of antioxidant) can help protect the kidneys during cisplatin chemotherapy. Cisplatin is a common cancer drug but can sometimes harm the kidneys, so this trial aims to see if adding this supplement reduces that risk.
This study tests whether a medicine called cilastatin can prevent kidney damage caused by certain strong medications. If you are receiving one of these medications and are at risk for kidney injury, this trial may offer protection.
This trial tests two drugs (cilastatin and thiosulfate) to see which one better protects the kidneys during surgery that uses heated cisplatin chemotherapy directly in the abdomen. It is for women with advanced ovarian cancer whose disease is mostly in the belly.
This Phase 2 trial tests whether sodium thiosulfate and mannitol can reduce hearing damage (ototoxicity) in adults receiving cisplatin chemotherapy. It may help protect hearing while you get cancer treatment.
This trial tests if a supplement called L-carnitine can help prevent kidney damage caused by the chemotherapy drug cisplatin. It may be an option for newly diagnosed cancer patients who need cisplatin treatment.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.